AN EXPLORATION OF FACTORS THAT MAY INFLUENCE RACIAL AND ETHNIC DIVERSITY IN CLINICAL TRIAL POPULATIONS IN THE US FOOD AND DRUG ADMINISTRATION'S (FDA) DRUG TRIALS SNAPSHOTS.

被引：0

|

作者：

Chege, W. ^{[1
]}

Suleyman, S. ^{[2
]}

Shepherd, J. ^{[1
]}

Watson, P. ^{[1
]}

Poddar, A. ^{[1
]}

Omokaro, S. ^{[1
]}

Fienkeng, M. ^{[1
]}

Crentsil, V. ^{[1
]}

Budashewitz, P. ^{[1
]}

ElZarrad, M. ^{[1
]}

机构：

[1] US FDA, Silver Spring, MD USA

[2] GlaxoSmithKline, Rockville, MD USA

来源：

CLINICAL PHARMACOLOGY & THERAPEUTICS | 2022年 / 111卷

关键词：

D O I：

暂无

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

PW-009

引用

收藏

页码：S71 / S71

页数：1

相关论文

共 22 条

[21] Discussion: Five-Year Follow-Up Data from the US Clinical Trial for Sientra's US Food and Drug Administration-Approved Silimed® Brand Round and Shaped Implants with High-Strength Silicone Gel
Saltz, Renato
PLASTIC AND RECONSTRUCTIVE SURGERY, 2012, 130 (05) : 982 - 983
[22] Five-Year Follow-Up Data from the U. S. Clinical Trial for Sientra's US Food and Drug Administration-Approved Silimed® Brand Round and Shaped Implants with High-Strength Silicone Gel
Stevens, W. Grant
Harrington, Jennifer
Alizadeh, Kaveh
Berger, Lewis
Broadway, David
Hester, T. Roderick
Kress, Donald
d'Incelli, Rosalyn
Kuhne, Joann
Beckstrand, Maggi
PLASTIC AND RECONSTRUCTIVE SURGERY, 2012, 130 (05) : 973 - 981